Insider · CIK 0001476151

Conterno Enrique A

Reports to the SEC for 2 companies · INDIANAPOLIS, IN

sec.gov

Transactions

Companies

Filings

CIK

0001476151

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-07-07	KYNBKYNTRA BIO, INC.S Sale	Director, Chief Executive Officer	SSale	−1,880 sh	$2.80	−$5,264	374,722
2023-06-07	KYNBKYNTRA BIO, INC.S Sale	Director, Chief Executive Officer	SSale	−2,791 sh	$17.04	−$47.5K	382,708
2023-06-07	KYNBKYNTRA BIO, INC.S Sale	Director, Chief Executive Officer	SSale	−6,106 sh	$17.04	−$104K	376,602
2023-04-10	KYNBKYNTRA BIO, INC.S Sale	Director, Chief Executive Officer	SSale	−1,869 sh	$19.52	−$36.5K	382,999
2023-03-10	KYNBKYNTRA BIO, INC.S Sale	Director, Chief Executive Officer	SSale	−12.1K sh	$20.20	−$244K	404,357
2023-03-10	KYNBKYNTRA BIO, INC.S Sale	Director, Chief Executive Officer	SSale	−19.5K sh	$20.20	−$394K	384,868
2023-03-10	KYNBKYNTRA BIO, INC.S Sale	Director, Chief Executive Officer	SSale	−19.5K sh	$20.20	−$394K	384,868
2023-03-08	KYNBKYNTRA BIO, INC.A Award	Director, Chief Executive Officer	AAward	+23.1K sh	—	—	379,231
2023-03-08	KYNBKYNTRA BIO, INC.S Sale	Director, Chief Executive Officer	SSale	−24.7K sh	$21.16	−$522K	356,111
2023-03-08	KYNBKYNTRA BIO, INC.A Award	Director, Chief Executive Officer	AAward	+37.2K sh	—	—	416,460
2023-02-21	KYNBKYNTRA BIO, INC.A Award	Director, Chief Executive Officer	AAward	+85.3K sh	—	—	380,783
2023-02-21	KYNBKYNTRA BIO, INC. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+143K sh	—	—	143,100
2023-01-06	KYNBKYNTRA BIO, INC.S Sale	Director, Chief Executive Officer	SSale	−1,538 sh	$19.95	−$30.7K	295,483
2022-12-08	KYNBKYNTRA BIO, INC.S Sale	Director, Chief Executive Officer	SSale	−2,543 sh	$15.79	−$40.2K	297,020
2022-10-06	KYNBKYNTRA BIO, INC.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−1,296 sh	$14.26	−$18.5K	299,563
2022-09-06	KYNBKYNTRA BIO, INC.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−1,772 sh	$12.26	−$21.7K	300,859
2022-07-06	KYNBKYNTRA BIO, INC.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−1,296 sh	$12.40	−$16.1K	302,631
2022-06-06	KYNBKYNTRA BIO, INC.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−1,772 sh	$9.50	−$16.8K	301,940
2022-04-07	KYNBKYNTRA BIO, INC.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−1,311 sh	$12.73	−$16.7K	303,712
2022-03-07	KYNBKYNTRA BIO, INC.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−7,081 sh	$12.69	−$89.9K	305,023
2022-02-14	KYNBKYNTRA BIO, INC. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+298K sh	—	—	298,000
2022-02-14	KYNBKYNTRA BIO, INC.A Award	Director, Chief Executive Officer	AAward	+179K sh	—	—	312,104
2022-01-06	KYNBKYNTRA BIO, INC.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−1,536 sh	$13.93	−$21.4K	132,704
2021-10-06	KYNBKYNTRA BIO, INC.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−1,859 sh	$10.20	−$19K	134,239
2021-07-06	KYNBKYNTRA BIO, INC.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−1,859 sh	$25.06	−$46.6K	136,098
2021-02-24	KYNBKYNTRA BIO, INC. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+164K sh	—	—	164,000
2021-02-24	KYNBKYNTRA BIO, INC.A Award	Director, Chief Executive Officer	AAward	+82K sh	—	—	137,273
2021-01-06	KYNBKYNTRA BIO, INC.F Tax Payment	Director, Chief Executive Officer	FTax Payment	−5,411 sh	$38.31	−$207K	55,273
2020-06-11	KYNBKYNTRA BIO, INC.P Purchase	Director, Chief Executive Officer	PPurchase	+19.8K sh	$35.28	+$699K	27,800
2020-06-10	KYNBKYNTRA BIO, INC.P Purchase	Director, Chief Executive Officer	PPurchase	+8,000 sh	$36.29	+$290K	8,000
2020-01-06	KYNBKYNTRA BIO, INC. · Stock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+300K sh	—	—	300,000
2020-01-06	KYNBKYNTRA BIO, INC.A Award	Director, Chief Executive Officer	AAward	+60K sh	—	—	60,000
2019-02-15	LLYELI LILLY & CoS Sale	SVP&Pres, LillyDiab & LillyUSA	SSale	−25K sh	$121.00	−$3.03M	132,962
2019-02-04	LLYELI LILLY & Co · Restricted Stock UnitA Award	SVP&Pres, LillyDiab & LillyUSA	AAward	+20.4K sh	—	—	20,397
2019-02-04	LLYELI LILLY & CoA Award	SVP&Pres, LillyDiab & LillyUSA	AAward	+26.7K sh	$120.17	+$3.21M	157,961
2019-02-04	LLYELI LILLY & CoA Award	SVP&Pres, LillyDiab & LillyUSA	AAward	+26.7K sh	$120.17	+$3.21M	157,962
2019-02-01	LLYELI LILLY & CoM Exercise/Conversion	SVP&Pres, LillyDiab & LillyUSA	MExercise/Conversion	+12.2K sh	—	—	136,756
2019-02-01	LLYELI LILLY & Co · Restricted Stock UnitM Exercise/Conversion	SVP&Pres, LillyDiab & LillyUSA	MExercise/Conversion	−12.2K sh	—	—	0
2019-02-01	LLYELI LILLY & CoF Tax Payment	SVP&Pres, LillyDiab & LillyUSA	FTax Payment	−5,476 sh	$119.86	−$656K	131,280
2018-05-31	LLYELI LILLY & CoS Sale	SVP&Pres, LillyDiab & LillyUSA	SSale	−25K sh	$85.00	−$2.13M	124,534
2018-05-01	LLYELI LILLY & CoF Tax Payment	SVP&Pres, LillyDiab & LillyUSA	FTax Payment	−8,934 sh	$81.07	−$724K	149,534
2018-05-01	LLYELI LILLY & Co · Restricted Stock UnitM Exercise/Conversion	SVP&Pres, LillyDiab & LillyUSA	MExercise/Conversion	−20K sh	—	—	0
2018-05-01	LLYELI LILLY & CoM Exercise/Conversion	SVP&Pres, LillyDiab & LillyUSA	MExercise/Conversion	+20K sh	—	—	158,468
2018-02-01	LLYELI LILLY & CoM Exercise/Conversion	SVP&Pres, LillyDiab & LillyUSA	MExercise/Conversion	+21.3K sh	—	—	147,980
2018-02-01	LLYELI LILLY & Co · Restricted Stock UnitM Exercise/Conversion	SVP&Pres, LillyDiab & LillyUSA	MExercise/Conversion	−21.3K sh	—	—	0
2018-02-01	LLYELI LILLY & CoF Tax Payment	SVP&Pres, LillyDiab & LillyUSA	FTax Payment	−9,512 sh	$81.45	−$775K	138,468
2018-01-29	LLYELI LILLY & Co · Restricted Stock UnitA Award	SVP&Pres, LillyDiab & LillyUSA	AAward	+12.2K sh	—	—	12,222
2018-01-29	LLYELI LILLY & CoA Award	SVP&Pres, LillyDiab & LillyUSA	AAward	+12.4K sh	$87.60	+$1.09M	126,654
2017-12-11	LLYELI LILLY & Co · Restricted Stock UnitA Award	SVP&Pres, LillyDiab & LillyUSA	AAward	+34.6K sh	—	—	34,615
2017-05-04	LLYELI LILLY & CoS Sale	SVP&Pres, LillyDiab & LillyUSA	SSale	−25K sh	$82.76	−$2.07M	114,217

Recent filings

Accepted (ET)
Jul 104
Conterno Enrique A0001209191-23-041969
SEC(opens sec.gov)
Jun 94
Conterno Enrique A0001209191-23-036051
SEC(opens sec.gov)
Apr 114
Conterno Enrique A0001209191-23-024026
SEC(opens sec.gov)
Mar 234/A
Conterno Enrique A0001209191-23-020781
SEC(opens sec.gov)
Mar 104
Conterno Enrique A0001209191-23-018064
SEC(opens sec.gov)
Feb 234
Conterno Enrique A0001209191-23-012423
SEC(opens sec.gov)
Jan 104
Conterno Enrique A0001209191-23-002803
SEC(opens sec.gov)
Dec 94
Conterno Enrique A0001209191-22-060580
SEC(opens sec.gov)
Oct 114
Conterno Enrique A0001209191-22-053355
SEC(opens sec.gov)
Sep 84
Conterno Enrique A0001209191-22-049223
SEC(opens sec.gov)
Jul 84
Conterno Enrique A0001209191-22-041664
SEC(opens sec.gov)
Jun 84
Conterno Enrique A0001209191-22-035219
SEC(opens sec.gov)
Apr 84
Conterno Enrique A0001209191-22-023840
SEC(opens sec.gov)
Mar 94
Conterno Enrique A0001209191-22-017646
SEC(opens sec.gov)

Companies

Address

LILLY CORPORATE CENTER

INDIANAPOLIS, IN, 46285